PRE 14A

PRE 14A

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: April 6, 2017
Period of Report: April 6, 2017
Accession Number: 0001144204-17-019437

View Document ↗ View on SEC.gov ↗